Kura Oncology (KURA) Tops Q4 EPS by 35c

Kura Oncology (NASDAQ: KURA) reported Q4 EPS of ($0.22), $0.35 better than the analyst estimate of ($0.57).

For earnings history and earnings-related data on Kura Oncology (KURA) click here.

You May Also Be Interested In

• Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
• Dawson Geophysical (DWSN) Reports Q2 Loss of $0.11
• Macrogenics (MGNX) Misses Q2 EPS by 102c